1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [33de885f-0d97-4bff-8329-1ba390dbfca8] => Array
        (
            [runtime-id] => 33de885f-0d97-4bff-8329-1ba390dbfca8
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [83228471-1499-410e-a32c-3f2cb6d0d97e] => Array
                        (
                            [runtime-id] => 83228471-1499-410e-a32c-3f2cb6d0d97e
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;2712e17a7d696b2cd184c7da03951f914831a748
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [33de885f-0d97-4bff-8329-1ba390dbfca8] => Array
        (
            [runtime-id] => 33de885f-0d97-4bff-8329-1ba390dbfca8
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [83228471-1499-410e-a32c-3f2cb6d0d97e] => Array
                        (
                            [runtime-id] => 83228471-1499-410e-a32c-3f2cb6d0d97e
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;2712e17a7d696b2cd184c7da03951f914831a748
                )

        )

)


Table 3: 
Multivariate logistic regression analysis: odds of complications according to platelet-testing status
ComplicationORa95% CIP Value
Primary outcome: neurologic morbidity and neurologic mortality2.370.95 to 5.93.06
Secondary outcomes
    Spontaneous rupture1.460.28 to 7.67.65
    Intracranial hemorrhage6.560.50 to 85.80.15
    Ischemic stroke2.030.67 to 6.20.21
    Parent artery stenosis0.06<0.001 to 24.51.37
    Cranial neuropathy1.170.22 to 6.38.85
    Neurologic mortality3.240.80 to 15.01.13
    Neurologic morbidity3.251.10 to 9.61.03
    All-cause mortality3.670.81 to 16.74.09
  • ↵a Shown are the odds in the platelet testing/PED group versus those in the PED alone group. For each of the complications, the OR is for the platelet testing/PED versus the PED alone group. The analysis was adjusted for age, gender, aneurysm size, number of aneurysms treated, use of multiple PEDs, practitioner's previous experience, and center volume.